3Dhar S,Pressman GS,Subramanian S. Natriuretic peptides and heart failure in the patient with chronic kidney disease:view of current evidence[J].Postgraduate Medical Journal,2009,(06):299-302.
4Waldo SW,Beede J,Isaksn S. Pro B-type natfiuretic peptide levels in acute decompensated heart failure[J].Journal of the American College of Cardiology,2008,(05):1874-1882.
5Roueff S,Martin E,Chauffert ML. Brain natriuretic peptide varia-tions are linked to volume status in hemodialysis patients[J].Clinical Nephrology,2008,(06):508-513.
6HARRED J F,KNIGHT A R,MCINTYRE J S. Inventorsdowchemical campany assignee xpxidation process[J].USPatent,2012,3( 17):1 927-1 904.
7ZHANGY LI W,YAN T. Early detection of lesions ofdorsal artery of foot in patients with type 2 diabetes melliusby high-frequency ultrasonography [J].J Huazhong UnivSci Technolog Med Sci,2011,29(3) :387-390.
8FOLEY R N , PARFHEYPS, SARNAK M J. Epidemiologyof cardiovasc-ular disease in chronic renal disease [j] JAm Soc Nephrol,2013,9 (12 Suppl) :S16-23.
9MALYSZKO J. Mechanism of end othelial dys sfunction inchronic kidney disease [J].Clin Chim Acta,2010,411(19/20):1412-1420.
10KEW J,REES G L,CLOSE D. Multiplanar reconstructedcomputed tomograhy images improves depicion and under-standing of the antomy of the frontal ntal sinus and recess[J].Am J Rhinol,2010,16(2):119-123.
